Viewing Study NCT04562792


Ignite Creation Date: 2025-12-24 @ 3:53 PM
Ignite Modification Date: 2026-02-17 @ 6:20 PM
Study NCT ID: NCT04562792
Status: COMPLETED
Last Update Posted: 2023-06-28
First Post: 2020-08-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia
Sponsor: Children's Mercy Hospital Kansas City
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed Pediatric ALL View
None Relapsed Pediatric AML View
None Refractory Acute Myeloid Leukemia View
None Refractory Acute Lymphoblastic Leukemia View
Keywords: